Eli Lilly stock price today was reported at $795.66, reflecting resilience despite broader Nasdaq softness. Market sentiment is bolstered by clinical trial progress and positive drug efficacy trends, underpinning growth expectations into Q Eli Lilly (LLY) shares climbed sharply after the White House announced a new platform for Americans to buy prescription drugs directly from manufacturers at a discount. This move removed uncertainty around future drug pricing policy. Here is how we make our selections: We focus on stocks with a market cap greater than $10 billion and filter out those with high CFO (cash flow from operations) margins or operating margins. We also consider only those stocks that have significantly decreased in valuation over the past year. Eli Lilly stock price today was quoted at $797.45, with RSI readings near 62, indicating healthy momentum without being overbought. Pharma sector flows remain supportive amid heightened healthcare policy debates.
